Clinical data revealed frequent coexistence of ASXL1 and SETBP1 mutations in myeloid neoplasms, and we previously demonstrated their cooperation to promote leukaemic transformation in mouse MDS/AML models19. Here, ASXL1 is linked to myelodysplastic syndrome.